UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024012
Receipt number R000027650
Scientific Title The usefulness and development of maggots therapy
Date of disclosure of the study information 2016/09/12
Last modified on 2023/09/22 11:15:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The usefulness and development of maggots therapy

Acronym

The usefulness and development of maggots therapy

Scientific Title

The usefulness and development of maggots therapy

Scientific Title:Acronym

The usefulness and development of maggots therapy

Region

Japan


Condition

Condition

intractable ulcer

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to verify the safety and efficacy of sterile maggots therapy for intractable ulcer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The presence or absence of adverse events, healing period

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Maggot therapy group

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with intractable ulcer

Key exclusion criteria

Tumor-bearing patients

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Toshikatsu
Middle name
Last name Igata

Organization

Kumamoto University

Division name

Department of Dermatology and Plastic Surgery

Zip code

8608556

Address

1-1-1-honjo-kumamoto-kumamoto-860-8556-japan

TEL

096-373-5233

Email

t-igata@ten-sun.net


Public contact

Name of contact person

1st name Toshikatsu
Middle name
Last name Igata

Organization

Kumamoto University

Division name

Department of Dermatology and Plastic Surgery

Zip code

8608556

Address

1-1-1-honjo-kumamoto-kumamoto-860-8556-japan

TEL

096-373-5233

Homepage URL


Email

t-igata@ten-sun.net


Sponsor or person

Institute

Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

Kumamoto University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

kumamoto univ. hospital

Address

kumamoto-shi, honjo 1-1-1

Tel

0963442111

Email

t-igata@ten-sun.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 12 Day


Related information

URL releasing protocol

-

Publication of results

Unpublished


Result

URL related to results and publications

-

Number of participants that the trial has enrolled

0

Results

Number of participants that the trial has enrolled is zero.

Results date posted

2023 Year 09 Month 22 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Number of participants that the trial has enrolled is zero.

Participant flow

Number of participants that the trial has enrolled is zero.

Adverse events

none

Outcome measures

Number of participants that the trial has enrolled is zero.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 07 Month 10 Day

Date of IRB

2014 Year 03 Month 24 Day

Anticipated trial start date

2014 Year 07 Month 10 Day

Last follow-up date

2019 Year 09 Month 21 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 12 Day

Last modified on

2023 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027650


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name